58 related articles for article (PubMed ID: 4345272)
21. Stereospecificity of hydride transfer and substrate specificity for FMN-containing NAD(P)H-flavin oxidoreductase from the luminescent bacterium, Vibrio fischeri ATCC 7744.
Inouye S; Nakamura H
Biochem Biophys Res Commun; 1994 Nov; 205(1):275-81. PubMed ID: 7999036
[TBL] [Abstract][Full Text] [Related]
22. Structure of archaeal glyoxylate reductase from Pyrococcus horikoshii OT3 complexed with nicotinamide adenine dinucleotide phosphate.
Yoshikawa S; Arai R; Kinoshita Y; Uchikubo-Kamo T; Wakamatsu T; Akasaka R; Masui R; Terada T; Kuramitsu S; Shirouzu M; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):357-65. PubMed ID: 17327673
[TBL] [Abstract][Full Text] [Related]
23. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase.
White PC; Rogoff D; McMillan DR
Curr Opin Pediatr; 2008 Aug; 20(4):453-7. PubMed ID: 18622204
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
[TBL] [Abstract][Full Text] [Related]
25. Species diversity of 11 beta-hydroxysteroid dehydrogenase in the cardiovascular system.
Slight S; Ganjam VK; Weber KT
J Lab Clin Med; 1994 Dec; 124(6):821-6. PubMed ID: 7798796
[TBL] [Abstract][Full Text] [Related]
26. Studies on the functional specificity of cortisone reductase.
Gibb W; Jeffery J
Biochem J; 1972 Jul; 128(4):136P. PubMed ID: 4344694
[No Abstract] [Full Text] [Related]
27. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.
Bonnac L; Gao GY; Chen L; Felczak K; Bennett EM; Xu H; Kim T; Liu N; Oh H; Tonge PJ; Pankiewicz KW
Bioorg Med Chem Lett; 2007 Aug; 17(16):4588-91. PubMed ID: 17560106
[TBL] [Abstract][Full Text] [Related]
28. [5 beta-steroid reductase activity of the soluble fraction of rat liver].
Korsova TL; Segal' GM
Biokhimiia; 1971; 36(2):253-7. PubMed ID: 5557812
[No Abstract] [Full Text] [Related]
29. Cloning and expression of two carbonyl reductase-like 20beta-hydroxysteroid dehydrogenase cDNAs in ovarian follicles of rainbow trout (Oncorhynchus mykiss).
Guan G; Tanaka M; Todo T; Young G; Yoshikuni M; Nagahama Y
Biochem Biophys Res Commun; 1999 Feb; 255(1):123-8. PubMed ID: 10082666
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of the transhydrogenase activity of spinach ferredoxin-Nicotinamide adenine dinucleotide phosphate reductase.
Fredricks WW; Kohlmann JM
J Biol Chem; 1969 Feb; 244(4):522-8. PubMed ID: 4388792
[No Abstract] [Full Text] [Related]
31. Radio-enzymic assay of oxo steroids by their reduction with the tritiated form of reduced nicotinamide--adenine dinucleotide.
Norymberski JK; Stoddart N; Wolstenholme JB
Biochem J; 1975 Jan; 145(1):47-51. PubMed ID: 172065
[TBL] [Abstract][Full Text] [Related]
32. [20 beta-Hydroxysteroid dehydrogenase, a new crystalline enzyme].
HUEBENER HJ; SAHRHOLZ FG; SCHMIDT-THOME J; NESEMANN G; JUNK R
Biochim Biophys Acta; 1959 Sep; 35():270-2. PubMed ID: 14403760
[No Abstract] [Full Text] [Related]
33. Some effects of ring-A structure on the interaction of 3-oxo-steroids of the androstane series with cortisone reductase.
Gibb W; Jeffery J
Eur J Biochem; 1972 Jan; 25(1):136-40. PubMed ID: 4336850
[No Abstract] [Full Text] [Related]
34. [20 beta-Hydroxysteroid dehydrogenase. 2. Preparation and crystallization].
HUEBENER HJ; SAHRHOLZ FG
Biochem Z; 1960; 333():95-105. PubMed ID: 14403761
[No Abstract] [Full Text] [Related]
35. [Use of Huebener's 20 beta-hydroxysteroid dehydrogenase in the microchemical identification and separation of steroids].
HENNING HD; ZANDER J
Hoppe Seylers Z Physiol Chem; 1962 Dec; 330():31-7. PubMed ID: 13953773
[No Abstract] [Full Text] [Related]
36. The function of cortisone reductase with 20-oxo steroid substrates differing in ring A.
White IH; Jeffery J
Biochem J; 1972 Feb; 126(3):10P. PubMed ID: 5075234
[No Abstract] [Full Text] [Related]
37. Structural requirements in 20-oxo-steroids for interaction with the binding site of 20beta-hydroxysteroid dehydrogenase.
Kawamura J; Tanimoto T; Fukuda H; Hayakawa T
Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):476-84. PubMed ID: 6944159
[No Abstract] [Full Text] [Related]
38. Reaction mechanism of 20 beta-hydroxysteroid dehydrogenase determined by equilibrium rate exchange.
Betz G; Taylor P
Arch Biochem Biophys; 1970 Mar; 137(1):109-14. PubMed ID: 4314053
[No Abstract] [Full Text] [Related]
39. Purification and properties of a sheep liver 21-hydroxysteroid nictoinamide adenine dinucleotide oxidoreductase.
MONDER C; WHITE A
J Biol Chem; 1963 Feb; 238():767-74. PubMed ID: 13936004
[No Abstract] [Full Text] [Related]
40. Formation of malonate-semialdehyde: nicotinamide adenine dinucleotide (NAD) oxidoreductase in Pseudomonas fluorescens P-2.
Mäntsälä P; Pirttikoski M; Nurmikko V
Acta Chem Scand; 1972; 26(1):395-6. PubMed ID: 4336653
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
